Office of Research on Women’s Health (ORWH)
Posted September 11, 2014
When NIH Director Dr. Francis S. Collins and I announced NIH’s decision to develop policies that will require applicants to address the influence of sex in preclinical research, we set the stage for an important conversation.
Since May, we have been pleased to hear from a number of researchers who are excited about the rollout of this policy. Many of you noted that you’d hoped NIH would make this change for some time.
We’ve also heard from others who have concerns, including how this policy might affect different types of research, how best to include both females and males in research, and what this means for funding. Many scientists and advocates have expressed the need for this change to be carefully implemented, as a true benefit to science — and not become a trivial, bureaucratic box to check. The powerful potential for improving the health of men and women is at stake, and we want to create meaningful change in a deliberate and thoughtful way. So, to begin the development of this policy, we want to hear from you.
Today the NIH Office of Extramural Research released a Request for Information (RFI): Consideration of Sex as a Biological Variable in Biomedical Research. This RFI seeks input from the research community and other interested stakeholders to share their perspectives on key questions about the consideration of sex in NIH-funded studies.
As Deputy Director for Extramural Research Dr. Sally Rockey noted in her blog post today, “Your input will help us shape policies that enhance the rigor of biomedical research, and in turn strengthen the foundation of clinical research.”
Thoughtful input from scientists, institutions, the medical community, professional societies, patients, and everyone who plays a role in the biomedical research enterprise will help us develop policies to ensure that NIH supports the most rigorously designed research studies that will transform discovery and health.
I hope that you will share your perspectives on this important change. NIH’s Office of Extramural Research has set up a website to collect your feedback: Tell us what you think, what you know, and what you’d like to know. I look forward to continuing this critical conversation.
Janine Austin Clayton, M.D.
Director, Office of Research on Women’s Health
Associate Director for Research on Women’s Health, NIH
Department of Health and Human Services
Recent Director’s Articles
Answering Questions on Considering Males and Females in Preclinical Research
Since announcing in Nature that NIH will require a deliberate approach in considering sex in preclinical research, we have heard from nearly every sector of the biomedical research community on this upcoming policy change.
Women Can Soar in STEM
Today I’m at the White House Summit on Working Families, which convenes businesses, economists, labor leaders, legislators, advocates, the media, and ordinary citizens to discuss issues facing the entire spectrum of working families in America.
About the ORWH Director
Janine Austin Clayton, M.D., was appointed Director for the NIH Office of Research on Women’s Health (ORWH) and Associate Director for NIH Research on Women’s Health by NIH Director Francis S. Collins, M.D., Ph.D., on September 4, 2012.
Dr. Clayton and ORWH in the News
- In a Nature Comment published on May 14, 2014, Dr. Francis Collins and Dr. Janine Clayton outlined NIH steps to address sex differences in preclinical research. This news was covered widely in the media. (May 2014)
- Labs Are Told to Start Including a Neglected Variable: Females , New York Times
- Medical research still short on inclusion of women , USA Today
- Needed: More Females in Animal and Cell Studies , Science magazine
- U.S. health agency to erase sex bias in biomedical studies , The Washington Post, The Chicago Tribune (Reuters)
- Mostly Male, Nature podcast , Nature
- More »